For citations:
Besova NS, Titova TA, Stroyakovsky DL, Perminova EV, Bagrova SG, Obarevich ES, Gorbunova VA, Artamonova EV, Stilidi IS. Results of the use of ramucirumab in combination with irinotecan and fluoropyrimidines in the second-line chemotherapy for disseminated gastric cancer. Meditsinskiy sovet = Medical Council. 2019;(10):100-109. (In Russ.) https://doi.org/10.21518/2079-701X-2019-10-100-109